Literature DB >> 2461985

Analysis of autoantibody binding to different regions of the human La antigen expressed in recombinant fusion proteins.

E W St Clair1, D S Pisetsky, C F Reich, J D Keene.   

Abstract

To determine the specificity of autoantibodies for various antigenic sites on a self-protein molecule, sera from 19 patients with anti-La antibodies were tested for their reactivity with molecularly cloned La protein fragments. By quantitative ELISA, anti-La sera from patients with various connective tissue diseases were shown to react with La fusion proteins containing different regions of the La molecule. Two recombinant La fragments containing the carboxyl three-fourths and the middle one-third of the La sequence, respectively, bound higher levels of anti-La antibodies than the two fragments representing the amino and carboxyl terminals. Purified bovine La protein effectively competed for the binding of human autoantibodies to three of the four recombinant La fusion proteins, suggesting similarity in antigenic presentation between the La epitopes in these fusion proteins and the native La molecule. Immunoadsorption experiments showed that most anti-bovine La protein antibodies were removed from a human serum by affinity chromatography by using the fusion protein containing the carboxyl three-fourths of the La sequence, thus supporting the results obtained by quantitative solid phase ELISA. These studies demonstrate that anti-La autoantibodies recognize three La fragments representing separate nonoverlapping regions of the La sequence and are compatible with a mechanism of autoantibody production based on an immune response to the entire self-protein molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461985

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 3.  cDNA cloning of small nuclear and cytoplasmic RNA-associated proteins.

Authors:  A van Dam; I Winkel; R Smeenk; T Cuypers
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Estimation of amounts of anti-La(SS-B) antibody directed against immunodominant epitopes of the La(SS-B) autoantigen.

Authors:  T P Gordon; M Greer; P Reynolds; A Guidolin; L J McNeilage
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

5.  A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein.

Authors:  R H Scofield; W D Dickey; K W Jackson; J A James; J B Harley
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

Review 6.  Structure and function of La and Ro RNPs.

Authors:  G J Pruijn; R L Slobbe; W J Van Venrooij
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

Review 7.  Interactions between autoimmunity and molecular and cell biology. Bridges between clinical and basic sciences.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

8.  Temporal correlation of antibody responses to different epitopes of the human La autoantigen.

Authors:  E W St Clair; J A Burch; M M Ward; J D Keene; D S Pisetsky
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 9.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

10.  Identification of a human-specific epitope in a conserved region of the La/SS-B autoantigen.

Authors:  Y M Weng; J McNeilage; F Topfer; J McCluskey; T Gordon
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.